| Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels A Piouka, D Farmakiotis, I Katsikis, D Macut, S Gerou, D Panidis American Journal of Physiology-Endocrinology And Metabolism 296 (2), E238-E243, 2009 | 405 | 2009 |
| Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis KA Toulis, DG Goulis, D Farmakiotis, NA Georgopoulos, I Katsikis, ... Human reproduction update 15 (3), 297-307, 2009 | 386 | 2009 |
| Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin E Diamanti-Kandarakis, T Paterakis, K Alexandraki, C Piperi, A Aessopos, ... Human Reproduction 21 (6), 1426-1431, 2006 | 315 | 2006 |
| Inflammatory and endothelial markers in women with polycystic ovary syndrome E Diamanti‐Kandarakis, K Alexandraki, C Piperi, A Protogerou, I Katsikis, ... European journal of clinical investigation 36 (10), 691-697, 2006 | 237 | 2006 |
| Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS) E Diamanti‐Kandarakis, I Katsikis, C Piperi, E Kandaraki, A Piouka, ... Clinical endocrinology 69 (4), 634-641, 2008 | 231 | 2008 |
| Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome D Panidis, C Balaris, D Farmakiotis, D Rousso, A Kourtis, V Balaris, ... Clinical chemistry 51 (9), 1691-1697, 2005 | 212 | 2005 |
| Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study D Panidis, K Tziomalos, G Misichronis, E Papadakis, G Betsas, I Katsikis, ... Human reproduction 27 (2), 541-549, 2012 | 190 | 2012 |
| Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels D Panidis, D Farmakiotis, D Rousso, A Kourtis, I Katsikis, G Krassas Fertility and sterility 89 (4), 899-906, 2008 | 141 | 2008 |
| Genetics of polycystic ovary syndrome N Prapas, A Karkanaki, I Prapas, I Kalogiannidis, I Katsikis, D Panidis Hippokratia 13 (4), 216, 2009 | 138 | 2009 |
| Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome D Macut, K Tziomalos, I Božić-Antić, J Bjekić-Macut, I Katsikis, ... Human reproduction 31 (6), 1347-1353, 2016 | 132 | 2016 |
| Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome D Panidis, D Rousso, G Koliakos, A Kourtis, I Katsikis, D Farmakiotis, ... Fertility and sterility 85 (6), 1778-1783, 2006 | 120 | 2006 |
| Adenomyosis: what is the impact on fertility? IM Matalliotakis, IK Katsikis, DK Panidis Current Opinion in Obstetrics and Gynecology 17 (3), 261-264, 2005 | 116 | 2005 |
| Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility D Panidis, K Tziomalos, E Papadakis, C Vosnakis, P Chatzis, I Katsikis Endocrine 44, 583-590, 2013 | 113 | 2013 |
| Prevalence of metabolic syndrome in women with polycystic ovary syndrome D Panidis, D Macut, K Tziomalos, E Papadakis, K Mikhailidis, ... Clinical endocrinology 78 (4), 586-592, 2013 | 110 | 2013 |
| Plasma visfatin levels in normal weight women with polycystic ovary syndrome D Panidis, D Farmakiotis, D Rousso, I Katsikis, D Delkos, A Piouka, ... European journal of internal medicine 19 (6), 406-412, 2008 | 92 | 2008 |
| Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome E Diamanti-Kandarakis, K Alexandraki, C Piperi, A Aessopos, T Paterakis, ... Metabolism 56 (1), 129-134, 2007 | 92 | 2007 |
| Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome E Diamanti-Kandarakis, A Piouka, S Livadas, C Piperi, I Katsikis, ... European journal of endocrinology 160 (5), 847-853, 2009 | 91 | 2009 |
| Effect of long‐term orlistat treatment on serum levels of advanced glycation end‐products in women with polycystic ovary syndrome E Diamanti‐Kandarakis, I Katsikis, C Piperi, K Alexandraki, D Panidis Clinical endocrinology 66 (1), 103-109, 2007 | 86 | 2007 |
| Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study D Florakis, E Diamanti-Kandarakis, I Katsikis, GP Nassis, A Karkanaki, ... International journal of obesity 32 (4), 692-699, 2008 | 77 | 2008 |
| The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia D Panidis, NA Georgopoulos, A Piouka, I Katsikis, AD Saltamavros, ... Gynecological Endocrinology 27 (8), 587-592, 2011 | 74 | 2011 |
Dimitrios FarmakiotisAssociate Professor of Medicine, Warren Alpert Medical School of Brown UniversityVerified email at lifespan.org
